CVAS-an interesting california-based biotech company here Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CVAS-an interesting california-based biotech company here

CVAS 0.000400

0.0%

Oct 7 9:32 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (105)	11/5/2002 10:32:26 PM
From: Miljenko Zuanic	Read Replies (1) of 126

It sound like very optimistic plan for PII. First phase should be completed fairly quickly, IF there is interest for new modality. <<The primary outcome measurement will be significant bleeding using contemporary criteria with secondary efficacy endpoints to include recurrent myocardial ischemia using continuous electrocardiographic monitoring over 7 days using portable Holter devices.>>

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next